col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


45 Ergebisse       Seite 1

 [1] 
Elsevier: Clinical Therapeutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Okt―31 Potential Signals of COVID-19 as an Effect Modifier of Adverse Drug Reactions Manfred Hauben, Eric Hung, Yan Chen
2 [GO] 2023―Okt―30 Cost-effectiveness Analysis and Impact on Length of Hospital Stay of the Introduction of Remdesivir as a Treatment Option for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen in Greece Versus Standard of Care Kostas Athanasakis, Konstantinos Zisis, Christos Tsoulas, Nikolaos Nomikos
3 [GO] 2023―Sep―26 The Utility of a Social Listening Program to Support Safety Surveillance of Tozinameran (COVID-19 Vaccine)-a Brief Survey of Pharmacovigilance Professionals Manfred Hauben
4 [GO] 2023―Sep―26 Intersection of Coronavirus Disease 2019 and Alcohol-associated Liver Disease: A Review of Emerging Trends and Implications Elizabeth S. Aby, Alexander S. Vogel, Adam C. Winters
5 [GO] 2023―Jul―29 Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report Fernanda Isadora Corona-Meraz, Blanca Perla Quintero-Castillo, Luis Alexis Hernández-Palma, Andrea Carolina Machado-Sulbaran
6 [GO] 2023―Apr―27 Drug-Drug Interactions - An Overlooked Dimension of the COVID-19 Pandemic Paul Beninger
7 [GO] 2023―Mrz―24 Prevalence of Potential Drug-Drug Interactions with Ritonavir-Containing COVID-19 therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, Jeffrey Brown, Marissa Grifasi Williams, Amy Puenpatom
8 [GO] 2023―Jan―16 The impact of the COVID-19 pandemic on antiasthmatics’ prescription: a nationwide study Tânia Magalhães Silva, Bernardo Sousa Pinto, Inês Cunha, Fátima Roque, Adolfo Figueiras, João Fonseca, et al. (+2)
9 [GO] 2022―Okt―24 Immunogenicity and Safety of SpikoGen®, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-Arm Clinical Trial Mohsen Nafar, Narges Mostafaloo, Ahmad Firouzan, Fatemeh Poorrezagholi, Fariba Samadian, Nooshin Dalili, et al. (+7)
10 [GO] 2022―Jul―25 Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems and Processes of Large, Medium, and Small Companies: An Industry Survey Paul Beninger, Patrick Caubel, Latika Sharma, Geo Pajovich, Pete Boyd
11 [GO] 2022―Mai―13 Reproductive Health and Coronavirus Disease 2019-Induced Economic Contracture: Lessons From the Great Recession LeAnn Louis, Angela Frankel, Asha Ayub, Tatum Williamson, Ashley Hanes, Megan L. Evans
12 [GO] 2022―Jan―29 Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-Based Pediatric COVID-19 Vaccine Delivery Annika M. Hofstetter, Suchitra Rao, Ravi Jhaveri
13 [GO] 2022―Jan―17 Early use of remdesivir and risk of disease progression in hospitalized patients with mild-to moderate COVID-19 Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Chiara Barbieri, Lisa Giusti, Valentina Galfo, et al. (+7)
14 [GO] 2022―Jan―10 COVID-19 made the impossible possible - Rolling Reviews from a notion to reality - the EU experience put into a global context Roelie Marinus, Sarah Mofid, Marya Mpandzou, Thomas C. Kühler
15 [GO] 2021―Nov―25 One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business Ravi Jhaveri
16 [GO] 2021―Nov―16 Willingness to Accept Expedited COVID-19 Vaccine Research for Children Under 12 Years after Adult Vaccine Approval Ran D. Goldman, Jeffrey N Bone, Renana Gelernter, Danna Krupik, Eileen J. Klein, Mark A. Griffiths, Ahmed Mater
17 [GO] 2021―Okt―13 The utility of remote inspections during the COVID-19 health emergency and in the post-pandemic setting Sarah Mofid, Winona Rei Bolislis, Clive Brading, Nigel Hamilton, Cyril Hardit, Makoto Nagaoka, et al. (+3)
18 [GO] 2021―Okt―04 Cost-effectiveness of Baricitinib Compared with Standard of Care in Hospitalized Patients With COVID-19 in the United States: A Modelling Study Robert Ohsfeldt, Kari Kelton, Tim Klein, Mark Belger, Patrick L. Mc Collam, Theodore Spiro, et al. (+2)
19 [GO] 2021―Sep―10 How COVID-19 is Helping Us Learn More about Diabetes Pathogenesis Ravi Jhaveri
20 [GO] 2021―Aug―23 Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled Phase 1 Studies in Healthy Subjects and Patients with Mild SARS-CoV-2 Infection Jin Yong Kim, Young Rock Jang, Jang Hee Hong, Jin Gyu Jung, Jae-Hyeong Park, Adrian Streinu-Cercel, et al. (+13)
21 [GO] 2021―Aug―05 Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John S. Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, et al. (+2)
22 [GO] 2021―Jul―26 Conversations with the Editors: The Emergence of Variants Amidst Population-Wide SARS-CoV-2 Vaccination Efforts-How Much Should We Worry? Egon Ozer, Larry K. Kociolek, Ravi Jhaveri
23 [GO] 2021―Jul―12 Ivermectin for coronavirus disease 2019: Yet to be well evaluated before clinical use Hideharu Hagiya, Fumio Otsuka
24 [GO] 2021―Mai―24 Exploration and Ethical Analysis of Open-Label Pediatric Vaccine Trials in a Pandemic Ian D. Wolfe, Angira Patel, Larry K. Kociolek, Asma Fazal, Ravi Jhaveri, John D. Lantos
25 [GO] 2021―Mai―06 Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John S. Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, et al. (+2)
26 [GO] 2021―Mai―06 SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations Ian D. Wolfe, Sameer J. Patel
27 [GO] 2021―Mai―05 COVID-19 Vaccine Effectiveness Richard I. Shader
28 [GO] 2021―Apr―16 Medication utilization among COVID-19 patients in a large, national dataset: Cerner Real-World Data™ Stephanie J. Stroever, Daniel Ostapenko, Robyn Scatena, Daniel Pusztai, Lauren Coritt, Paul Nee
29 [GO] 2021―Mrz―29 Using Machine Learning as a Precision Medicine Approach for Remdesivir and Corticosteroids as COVID-19 Pharmacotherapies Carson Lam, Anna Siefkas, Nicole S. Zelin, Gina Barnes, R. Phillip Dellinger, Jean-Louis Vincent, et al. (+6)
30 [GO] 2021―Mrz―23 The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World Ravi Jhaveri
31 [GO] 2021―Mrz―20 Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic Eman M. Alfadhli
32 [GO] 2021―Feb―26 Inpatient omission of ACEi and ARBs is associated with morbidity and mortality in COVID-19 Christopher Oddy, Jonathan Allignton, James McCaul, Polly Keeling, Dhanuja Senn, Neesha Soni, et al. (+4)
33 [GO] 2021―Jan―22 The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning? Ravi Jhaveri
34 [GO] 2021―Jan―18 Sex- or gender-specific differences in the clinical presentation, outcome, and treatment of Sars-Cov2 Jeannette Wolfe, Basmah Safdar, Tracy E. Madsen, Kinjal N. Sethuraman, Bruce Becker, Marna Rayl Greenberg, Alyson J. McGregor
35 [GO] 2021―Jan―15 Influence of COVID-19 on the Pharmacovigilance Workforce of the Future Paul Beninger
36 [GO] 2021―Jan―11 A critical appraisal of the effects of anesthetics on immune system modulation in critically ill patients with COVID-19 Athanasios Chalkias, Erin F. Barreto, Eleni Laou, Konstantina Kolonia, Marc H. Scheetz, Konstantinos Gourgoulianis, et al. (+2)
37 [GO] 2021―Jan―08 Differential expression of Rab5 and Rab7 small GTPase proteins in placental tissues from pregnancies affected by maternal COVID-19 Yoel Benarroch, Lillian Juttukonda, Vishakha Sabharwal, Jeffery Boateng, Amir R. Khan, Christina Yarrington, et al. (+2)
38 [GO] 2020―Dez―18 Global and Country Level Time Series Analyses of the Effect of the COVID-19 Pandemic on Spontaneous Reporting Manfred Hauben, Eric Hung
39 [GO] 2020―Nov―30 Regulatory agilities in the time of COVID-19: Overview, Trends and Opportunities Winona Rei Bolislis, Maria Lucia De Lucia, Felipe Dolz, Runyi Mo, Makoto Nagaoka, Heraclio Rodriguez, et al. (+3)
40 [GO] 2020―Okt―03 Caregivers’ willingness to accept expedited vaccine research during the COVID-19 pandemic - a cross sectional survey Ran D. Goldman, Shashidhar R. Marneni, Michelle Seiler, Julie C. Brown, Eileen J. Klein, Cristina Parra Cotanda, et al. (+34)
41 [GO] 2020―Aug―17 CoVid-19, Microthromboses and Platelet Activating Factor (PAF) Theoharis C. Theoharides, Smaragdi Antonopoulou, Constantinos A. Demopoulos
42 [GO] 2020―Jun―28 Covid-19: The Regulatory Landscape of Medicinal and Medical Device Products for Human Use Paul Beninger
43 [GO] 2020―Apr―27 Association Between Clinical Manifestations and Prognosis in Patients with COVID-19 Tao Yu, Shaohang Cai, Zhidan Zheng, Xuejuan Cai, Yuanyuan Liu, Sichun Yin, et al. (+2)
44 [GO] 2020―Apr―27 COVID-19 and Depression Richard I. Shader
45 [GO] 2020―Apr―11 Echoes of 2009 Pandemic H1N1 Influenza with the COVID Pandemic Ravi Jhaveri
 [1] 

45 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.022 sec